Neowise
Latest round
- Series B
Last raised
- Oct 2025
Total raised
- $57M
Investors
- 12
About Neowise
, dba Neowise is an innovative biotechnology company focused on the discovery and development of TCR-T (T-cell receptor-engineered T cell) therapies for the treatment of solid tumors. The company aims to expand therapeutic targets and improve treatment options for cancer patients through advanced immunocell therapy technologies., LTD. Neowise develops autologous TCR-T cell therapy drug candidates targeting tumor-associated antigens in solid tumors. Its core technology platform supports the discovery, validation, and development of antigen-specific TCRs, enabling multiple clinical-stage cell therapy pipelines. The company’s revenue sources include out-licensing or partnering of proprietary TCR assets and future commercialization of clinical-stage and approved TCR-T therapies for solid tumors.
Who invested in Neowise
12 investors across 4 rounds
See all investors in Neowise
Sign up free to see every VC on the cap table, the rounds they joined, and how much each round raised.
Questions about Neowise
Who invested in Neowise?
Neowise has 12 investors on record across 4 venture rounds. Sign up free to see every VC on the cap table and the rounds they joined.
How much funding has Neowise raised?
Neowise has raised 4 venture rounds. Sign up free to see how much each round raised and the total.
When did Neowise last raise money?
Neowise's most recent round on record is a Series B, in Oct 2025.
What does Neowise do?
, dba Neowise is an innovative biotechnology company focused on the discovery and development of TCR-T (T-cell receptor-engineered T cell) therapies for the treatment of solid tumors.
Where is Neowise headquartered?
Neowise is headquartered in Suzhou, China.
Which VCs invest in companies like Neowise?
Among active investors with capital left to deploy, Shanghai State-owned Capital Investment Leading Fund, Yufu Capital, ICBC Capital Management and Ningbo Tongshang Fund back biotechnology companies at Neowise's stage. Their profiles are linked below.
VCs backing biotechnology startups at Series B
Raising like Neowise? Find the right VCs.
Capital Atlas matches your startup to active investors by stage, sector and region.